Kishore Viswanathan

Title: Innovations of Kishore Viswanathan in Dihydrofolate Reductase Inhibition

Introduction

Kishore Viswanathan is an accomplished inventor based in Mansfield Center, CT (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for dihydrofolate reductase (DHFR). His work focuses on creating compounds that can effectively target and inhibit this crucial enzyme, which plays a vital role in various pathogenic organisms.

Latest Patents

Kishore Viswanathan holds a patent for "Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase." This patent describes the design, synthesis, and testing of compounds that act as inhibitors of DHFR. The basic scaffold of these inhibitors includes a 2,4-diaminopyrimidine ring with a propargyl linker to another substituted aryl, bicyclo, or heteroaryl ring. These DHFR inhibitors are noted for their potency and selectivity against various pathogenic organisms, including methicillin-resistant bacteria, fungi, and protozoa. Additionally, these compounds show potential against the mammalian enzyme and may serve as effective anti-cancer therapeutics.

Career Highlights

Kishore Viswanathan is affiliated with the University of Connecticut, where he continues to advance his research in the field of biochemistry. His innovative work has garnered attention for its potential applications in medicine and therapeutics.

Collaborations

Kishore has collaborated with notable colleagues, including Janet Leigh Paulsen and Dennis L Wright. These partnerships have contributed to the success of his research and the development of his patented compounds.

Conclusion

Kishore Viswanathan's contributions to the field of dihydrofolate reductase inhibition highlight his innovative spirit and dedication to advancing medical science. His work not only addresses critical health challenges but also opens new avenues for therapeutic development.